HOME › Research Insight › Players are Focusing on Adopting Organic and Inorganic Growth Strategies such as Partnerships, Agreements, Collaborations, Strategic Alliances, New Product Launches in Oligonucleotide Synthesis Market
Players are Focusing on Adopting Organic and Inorganic Growth Strategies such as Partnerships, Agreements, Collaborations, Strategic Alliances, New Product Launches in Oligonucleotide Synthesis Market
Key Players in the Oligonucleotide Synthesis Market Pursue Partnerships, Agreements, Collaboration, Alliances, Product Launches, Service Launches, Product Upgrade and Product Enhancement, Acquisition, and Expansion as their Key Growth Strategies.
Other players in the oligonucleotide synthesis market include GeneDesign, Inc. (Japan), TriLink BioTechnologies, Inc. (U.S.), GenScript (U.S.), ATDBio Ltd. (U.K.), Bio-Synthesis Inc. (U.S.), IBA GmbH (Germany), Gene Link Inc. (U.S.), and AITbiotech Pte. Ltd. (Singapore).
Integrated DNA Technologies (IDT) (U.S.) is among the leading players in the oligonucleotide synthesis market. The leading position of this company is mainly attributed to its robust product portfolio and brand recognition in the market. The company pursues product launch as its key growth strategy. For instance, in June 2015, it launched Minor Groove Binder (MGB) Eclipse GMP probes online, which made it easier for the company to reach out to its customers and vice versa. Similarly, in December 2015, it launched Prime Time Gene Expression Master Mix, which enhanced the product portfolio of the company. Besides product launch, the company also pursues the strategies of acquisitions, expansions, and collaborations. For instance, in June 2016, the company acquired MBiotech, Inc. (South Korea), a distributor of IDT products. This acquisition helps the company to deliver excellent products and services in South Korea. All such developments help the company to retain its leading position in the oligonucleotide synthesis market.
Moreover, Sigma Aldrich Corporation (U.S.) (part of Merck KGaA (Germany)) is one of the leading players in the market. The company is known for its robust product portfolio, and strong geographic presence. To leverage growth opportunities in the oligonucleotide synthesis market, the company focuses on adopting organic as well as inorganic growth strategies. For instance, in February 2015, the company launched custom next-generation sequencing adapters (oligos) that improve target sequence assembly. Such strategic steps taken by the company help it to further enhance its presence and increase its share in the oligonucleotide synthesis market.
Companies are focusing on adopting organic and inorganic growth strategies such as partnerships, agreements, collaborations, strategic alliances, new product launches, new service launches, product upgrade and product enhancement, acquisition, and expansion to synergistically develop advanced analytics solutions in the market. These strategies help market players to strengthen their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
The overall growth strategies mapped from 2013 to June 2016 include partnerships, agreements, collaborations, alliances, product launches, service launches, product upgrade and product enhancement, acquisition, and expansion. Partnerships, agreements, collaborations, and alliances accounted for the largest share of the overall strategic developments mapped in the above mentioned period. Agilent Technologies, Inc. (U.S.), Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), IDT (U.S.), Nitto Denko Avecia Inc. (U.S.), and Sigma-Aldrich Corporation (U.S.) (part of Merck KGaA) are the companies that majorly adopted these strategies.
Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India